Global EYLEA Drug - A Breakthrough In Treatment Of Retinal Diseases

added blog Other

2025-08-04 11:52:21 -

EYLEA – A Novel Drug for Retinal Diseases EYLEA (Aflibercept) is a vascular endothelial growth factor (VEGF) inhibitor developed by Regeneron Pharmaceuticals and Bayer for the treatment of various retinal diseases. It was approved by the US FDA in 2011 for treatment of wet age-related macular degeneration (AMD) and has since gained approval for other retinal conditions like diabetic...

0 Comments 0 Shares 72 Views 0 Reviews